Bioreactors Market Size Forecasted To Achieve 18.58 Billion By 2029 With Steady Growth

Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Is the Bioreactors Market Size and Projected Growth Rate?
The size of the bioreactors market has experienced swift growth in the recent past. The market is set to expand from a worth of $9.22 billion in 2024 to $10.64 billion in 2025, reflecting a compound annual growth rate (CAGR) of 15.2%. Factors such as the escalating demand for biopharmaceuticals, increase in cell and gene therapy research, a growing emphasis on personalized medicine, adoption of single-use bioreactor technology, and a requirement for efficient manufacturing processes, contributed to its growth in the historic period.

Over the coming years, the bioreactors market is anticipated to experience a swift expansion, reaching $18.58 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 14.9%. This projected increase during the forecast period can be credited to the surge in biotechnology research investments, the widespread occurrence of chronic diseases, escalating demand for vaccines and therapeutic proteins, an uptick in regulatory support for biomanufacturing, and an elevated utilization of advanced therapies. The era will also witness some key trends like progress in biotechnology, automation and control systems, enhancements in bioprocess development and manufacturing efficacy, as well as the burgeoning demand for scalable production solutions.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20721

What Are the Major Segments in the Bioreactors Market?
The bioreactors market covered in this report is segmented -

1) By Type Of Bioprocess: Batch And Fed-Batch, Continuous
2) By Cell: Mammalian Cells, Bacterial Cells, Yeast Cells, Other Cells
3) By Control: Manual, Automated
4) By Usage: Lab Scale Production, Pilot Scale Production, Full Scale Production
5) By End-Use: Research And Development (R&D) Organizations, Biopharmaceutical (Biopharma) Manufacturers, Contract Manufacturing Organizations (CMOS)

Subsegments:
1) By Batch And Fed-Batch: Traditional Batch Bioreactors, Fed-Batch Bioreactors
2) By Continuous: Perfusion Bioreactors, Continuous Stirred Tank Bioreactors (CSTR)

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20721&type=smp

What Are The Driving Bioreactors Market Evolution?
The growth of the bioreactors market is tipped to accelerate due to the rising demand for biopharmaceuticals. Biopharmaceuticals, medicinal products extracted from biological sources like proteins, cells, and living organisms, are employed in the mitigation, management, and treatment of a multitude of diseases. The surge in demand for these biopharmaceuticals is spurred by progress in medical research, the emergence of personalized medicine, and the pursuit for pioneering treatments, resulting in enhanced healthcare results globally. Bioreactors play a vital role in the production of biopharmaceuticals by facilitating cost-effective and scalable production, maintaining quality consistency, cutting down production expenses, and fostering the creation of innovative and life-improving medicines. As an illustration, Pharmaceutical Research and Manufacturers of America, a trade association based in the U.S, reported in May 2024 that the U.S. biopharmaceutical industry's total output surpassed $1.65 trillion in 2022, with direct production contributing $800 billion and another $800 billion from suppliers and other sectors, which made up 3.6% of the U.S. economy. Consequently, the swelling demand for biopharmaceuticals is fueling the expansion of the bioreactors market.

Which Firms Dominate The Bioreactors Market Segments?
Major companies operating in the bioreactors market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare Technologies Inc., Cytiva Bioscience Holding Ltd., Sartorius AG, Cellexus Ltd., Getinge AB, Eppendorf AG, ZETA Holding, Pierre Guerin, Broadley-James Corporation, PBS Biotech Inc., TAP Biosystems, Solida Biotech GmBH, BBI-Biotech GmbH, HiTec Zang GmbH, Xiamen Ollital Technology Co. Ltd., Bioengineering AG, Infors AG, Univercells Technologies SA, CerCell A/S, Bailun Biotechnology Co. Ltd., BioNet, Shanghai Ritai Medicine Equipment Project Co. Ltd.

What Trends Are Expected to Dominate the Acquired Autoimmune Hemolytic Anemia Market in the Next 5 Years?
Leading firms in the bioreactors market are concentrating their efforts on the creation of innovative products like fixed-bed bioreactors to aid in the development of increasingly intricate biological cultures. The fixed-bed bioreactor is an innovation where living organisms are bound to a solid medium, usually made up of porous substances like granules, beads, or fibers. This configuration fosters mass exchange, mitigates shear stress, and affords a heightened degree of control over biological procedures. For example, in October 2024, Univercells Technologies, a biotech firm based in Belgium, unveiled the Scale-X Nexo bioreactor. This state-of-the-art bioreactor, which has a 0.5 m2 growth area, is purposefully engineered to boost the efficiency of cell culture process expansion, bringing substantial advantages to both research organizations and biopharmaceutical enterprises. The Scale-X Nexo offers easy upscaling to larger versions, reduces the consumption of media and reagents and has the potential to cut operational expenditure by up to 60% when compared to conventional entry-level bioreactors. It's also compatible with the Skaia Vision application software, ensuring accurate cell count prediction without necessitating direct sampling, thereby enhancing output.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/bioreactors-global-market-report

Which Is The Largest Region In The Bioreactors Market?
North America was the largest region in the bioreactors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioreactors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Bioreactors Market?
2. What is the CAGR expected in the Bioreactors Market?
3. What Are the Key Innovations Transforming the Bioreactors Industry?
4. Which Region Is Leading the Bioreactors Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.